Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: US, State of the Art

Cancer of unknown primary

ABSTRACTCancers of unknown primary (CUPs) are histologically confirmed, metastatic malignancies with a primary tumor site that is unidentifiable […]

December 7, 2020 US, State of the Art

Treatment of epithelial ovarian cancer

ABSTRACTOvarian cancer is the third most common gynecologic malignancy worldwide but accounts for the highest mortality rate among […]

November 9, 2020 US, State of the Art

Management of hypertriglyceridemia

AbstractHypertriglyceridemia is one of the most common lipid abnormalities encountered in clinical practice. Many monogenic disorders causing severe […]

October 12, 2020 US, State of the Art

Hepatorenal syndrome: pathophysiology, diagnosis, and management

ABSTRACTHepatorenal syndrome (HRS), the extreme manifestation of renal impairment in patients with cirrhosis, is characterized by reduction in […]

September 14, 2020 US, State of the Art

Pulmonary embolism: update on management and controversies

ABSTRACTPulmonary embolism is a common and potentially fatal cardiovascular disorder that must be promptly diagnosed and treated. The […]

August 5, 2020 US, State of the Art

Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice

ABSTRACTDespite their ubiquitous presence, placebos and placebo effects retain an ambiguous and unsettling presence in biomedicine. Specifically focused […]

July 20, 2020 US, State of the Art

Advances in the diagnosis and management of IgG4 related disease

ABSTRACTIgG4 related disease was recognized as a unified disease entity only 15 years ago. Awareness of IgG4 related […]

June 16, 2020 US, State of the Art
p p Read More

Advances in regenerative medicine for otolaryngology/head and neck surgery

Posts navigation

Posts pagination

« Previous 1 2 3
Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy